HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1392900Generated: November 2, 2026
tert-Butyl 4-oxopiperidine-1-carboxylate → 1-tert-butoxycarbonyl-4-{4-[1 (S)-(4-bromophenyl)-ethyl]-3(R)-methylpiperazin-1-yl}-piperidine
https://huagongshe.com/reaction/1392900
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | tert-Butyl 4-oxopiperidine-1-carboxylate | HCID 735900 | — |
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Reactant | 1-[1-(4-Bromo-phenyl)-ethyl]-2-methyl-piperazine | HCID 64930707 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | 1-tert-butoxycarbonyl-4-{4-[1 (S)-(4-bromophenyl)-ethyl]-3(R)-methylpiperazin-1-yl}-piperidine | HCID 15407079 | — |
Reaction Steps
The product of step 4 was stirred for 20 h. at RT with N-Boc-4-piperidinone (4.32 g), HOAC (1.15 ml), CH2Cl2 (80 ml) and sodium triacetoxy-borohydride (NaBH(OAc)3) (8.3 g). Thereafter the reaction was quenched with excess aqueous Na2CO3 solution slowly and stirred for 0.5 h. The organic layer was separated and filtered through a pad of silca gel, washing with 10:1 CH2Cl2-Et2O to elute all of the product. The filtate was evaporated and dissolved in Et2O (100 ml). To this was added dropwise a 4M solution of HCl in 1,4-dioxane (10 ml). The solids were collected, washed with Et2O, and stirred with CH2Cl2 and excess aqueous NaOH. The organic phase was dried over K2CO3 and evaporated to obtain 1-tert-butoxycarbonyl-4-{4-[1 (S)-(4-bromophenyl)-ethyl]-3(R)-methylpiperazin-1-yl}-piperidine (5.45 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07345042B2 |
|---|
| Source dataset | uspto-grants-2008_03 |
|---|
| ORD ID | ord-affb486a76dc4bfc97e8478d0ef6fcac |
|---|
| Source note | uspto-grants-2008_03 |
|---|